Successful Briefing on Innovation in Cancer Detection
Yesterday Exact Sciences sponsored a very successful Congressional Staff briefing on Innovation in Cancer Detection. Exact Sciences has gained FDA and Medicare approval for Cologuard a non-invasive colon cancer screening test that detects 92% of colon cancer and 69% of advanced pre-cancer. Among the speakers were Kevin Conroy, CEO of Exact Sciences; Dr. David Ahlquist…